Live data from Hacker News

Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

fiercebiotech.com

61–70 of 1001 posts

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#61

Did anyone hear NPR's reporting on this? They said the early study was originally halted BECAUSE of it's positive effects at preventing hospitalization and death... very weird, I hope it is a typo or I'm understanding it wrong...

That’s correct. If a positive effect in the treatment arm of the study is found to be strong enough, it is deemed unethical to continue giving patients the placebo as control. Hence, they terminate the study and proceed to the next phase of approval

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#62
post #2

So as good as a vaccine basically?

Comparable individual outcome, worse societal outcome - you still spread it, so no reduction in overall cases, unlike a vaccine.

Yet, with the COVID vaccine, you still spread it, too:

https://theexpose.uk/wp-content/uploads/2021/09/Pierpont-Why...

https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7031e2-H.pdf

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3897733

So, how could the outcome at the societal level be worse?

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#63
post #5

> There were six hospitalizations and no deaths among the 607 patients who received Paxlovid within five days of symptom onset, compared to 41 hospitalizations and 10 deaths in the placebo cohort. How does this work? You sign up for the program when you're sick and you might get meds that help you? That would really suck if a loved one was in the program and died because they happened to get the placebo.

It's unusual but not unheard of for trials to be stopped ahead of schedule because of this - the treatment is so clearly and substantially beneficial it's considered unethical to continue depriving the control group of the treatment.

When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches:

https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.111...

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#65

Earlier quoted context omitted.

I'm excited to hear the results of the pill among the vaccinated. Cutting the risk of severe symptoms among high-risk vaccinated people, and the risk of long covid for everyone is very important. The vaccines are great, but not silver bullets themselves.

"Long covid" is an urban legend.

It does exist. Probably has the same symptoms as any other virus pneumonia.

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#66

Did anyone hear NPR's reporting on this? They said the early study was originally halted BECAUSE of it's positive effects at preventing hospitalization and death... very weird, I hope it is a typo or I'm understanding it wrong...

It's a semi common issue for highly effective novel treatments. In order to continue the study you need to keep some portion as a control group.

I can't imagine wanting to keep people in the control group when the experimental treatment is so dramatically effective.

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#67

So, is this expensive and patented and does it have limited availability?

Does it matter? Vaccine flows like water these days, and at least in the rich world, nearly everyone who needs this chose to be in that position. Making that choice should be incredibly costly.

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#68
post #5

> There were six hospitalizations and no deaths among the 607 patients who received Paxlovid within five days of symptom onset, compared to 41 hospitalizations and 10 deaths in the placebo cohort. How does this work? You sign up for the program when you're sick and you might get meds that help you? That would really suck if a loved one was in the program and died because they happened to get the placebo.

The alternative is what we have right now, ‘scientists’ blathering about their assumptions with the constant disclaimer that nobody really knows for real. Real science does have a price.

> Real science does have a price.

Part of that price is honesty on what's truly known, indicated, suggested, hypothesized, or unknown. What is "blathering" to you is intellectual integrity to others.

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#69

Did anyone hear NPR's reporting on this? They said the early study was originally halted BECAUSE of it's positive effects at preventing hospitalization and death... very weird, I hope it is a typo or I'm understanding it wrong...

If something proves to be too effective, too early in a trail, it's no longer ethical to give placebos to the control group.

Re: Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

#70
post #13

> Pfizer used data on patients who were treated within three days of symptom onset as the headline finding in its press release > There were six hospitalizations and no deaths among the 607 patients who received Paxlovid within five days of symptom onset, compared to 41 hospitalizations and 10 deaths in the placebo cohort. > Like Merck, Pfizer excluded people vaccinated against COVID-19 from its late-phase study. No…

If the cost is low enough and the side effects are mild enough it could work. People would take it before a test is positive so would end up taking it when they didn’t really need it.

It’s similar to the antivirals for flu where you need to take it early on so it becomes habit to test early and start early.

Home labs will help with this too. Where someone could take a test, get a prescription and pickup within a few hours.

Post reply on HN